Viewing Study NCT04160494

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:00 AM
Ignite Modification Date: 2026-03-08 @ 12:50 AM
Study NCT ID: NCT04160494
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-11
First Post: 2019-11-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: D2C7-IT With Atezolizumab for Recurrent Gliomas
Sponsor: Darell Bigner
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malignant Glioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None D2C7 View
None D2C7-IT View
None Atezolizumab View
None Randazzo View
None Glioblastoma View
None Glioma View
None Bigner View
None Pro00101898 View
None Genentech View
None CTEP View
None Duke View
None Landi View